Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
- 1 October 1994
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 90 (4), 2056-2069
- https://doi.org/10.1161/01.cir.90.4.2056
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- Magnesium deficiency and sudden deathAmerican Heart Journal, 1992
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Angiotensin II induces expression of the - gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1988
- Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular HypertrophyNew England Journal of Medicine, 1987
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failureAmerican Heart Journal, 1982